UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 46

Sortiert nach

A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study

International journal of cancer, 2013-08, Vol.133 (4), p.929-936

2013

Volltextzugriff (PDF)

Patient access to voice prostheses and heat and moisture exchangers: Factors influencing physician’s prescription and reimbursement in eight European countries

Oral oncology, 2019-04, Vol.91, p.56-64

2019

Volltextzugriff (PDF)

Scenario drafting for early technology assessment of next generation sequencing in clinical oncology

BMC cancer, 2016-02, Vol.16 (64), p.66-66, Article 66

2016

Volltextzugriff (PDF)

Prospective cost-effectiveness analysis of genomic profiling in breast cancer

European journal of cancer (1990), 2013-12, Vol.49 (18), p.3773-3779

2013

Volltextzugriff (PDF)

Improving the efficiency of a chemotherapy day unit: Applying a business approach to oncology

European journal of cancer (1990), 2009-03, Vol.45 (5), p.800-806

2009

Volltextzugriff (PDF)

Expert Elicitation Used for Early Technology Assessment to Inform on Cost-Effectiveness of Next Generation Sequencing

Value in health, 2014-11, Vol.17 (7), p.A652-A652

2014

Volltextzugriff (PDF)

Evaluating the cost-effectiveness of multicomponent rehabilitation guidelines

Value in health, 2013-05, Vol.16 (3), p.A30-A30

2013

Volltextzugriff (PDF)

SP-0544: Intensive physical training during adjuvant treatment

Radiotherapy and oncology, 2014, Vol.111, p.S213-S213

2014

Volltextzugriff (PDF)

Early Cost-Effectiveness Modeling for Tumor Infiltrating Lymphocytes (TIL) -Treatment Versus Ipilimumab in Metastatic Melanoma Patients

Value in health, 2014-11, Vol.17 (7), p.A640-A640

2014

Volltextzugriff (PDF)

Estimating the Voi of Pivotal Studies Towards Predictive Biomarkers of High Dose Alkylating Chemotherapy in Triple Negative Breast Cancer

Value in health, 2014-11, Vol.17 (7), p.A644-A644

2014

Volltextzugriff (PDF)

Early Stage Cost-Effectiveness Analysis of a Brca1-Like Test to Detect Triple Negative Breast Cancers Responsive to High Dose Alkylating Chemotherapy

Value in health, 2014-11, Vol.17 (7), p.A323-A323

2014

Volltextzugriff (PDF)

PMD25 FACTORS INFLUENCING PHYSICIAN'S PRESCRIPTION AND REIMBURSEMENT OF MEDICAL DEVICES USED IN LARYNGECTOMY REHABILITATION IN EUROPE

Value in health, 2019-05, Vol.22, p.S220-S220

2019

Volltextzugriff (PDF)

PNS57 BUDGET IMPACT ANALYSIS OF A WEARABLE REMOTE CONTINUOUS MONITORING DEVICE TO FACILITATE EARLY DISCHARGE OF BARIATRIC SURGERY PATIENTS IMMEDIATELY AFTER POSTOPERATIVE OBSERVATION IN THE RECOVERY WARD

Value in health, 2019-11, Vol.22, p.S772-S772

2019

Volltextzugriff (PDF)

Excellent translational research in oncology: A journey towards novel and more effective anti-cancer therapies

Molecular oncology, 2016-05, Vol.10 (5), p.645-651

2016

Volltextzugriff (PDF)

207 70-Gene Signature Prospectively Predicts Prognosis of Patients with Node-negative Breast Cancer: 5 Year Follow-up of the RASTER Study

European journal of cancer (1990), 2012-03, Vol.48, p.S104-S104

2012

Volltextzugriff (PDF)

Cost-Effectiveness Of Cognitive-Behavioral Therapy And Physical Exercise For Alleviating Treatment-Induced Menopausal Symptoms In Breast Cancer Patients

Value in health, 2013-05, Vol.16 (3), p.A141-A141

2013

Volltextzugriff (PDF)

Factors for a broad technology assessment of comprehensive genomic profiling in advanced cancer, a systematic review

Critical reviews in oncology/hematology, 2024-10, Vol.202, p.104441, Article 104441

2024

Volltextzugriff (PDF)

A revolving research fund to study efficient use of expensive drugs: big wheels keep on turning

Annals of oncology, 2021-10, Vol.32 (10), p.1212-1215

2021

Volltextzugriff (PDF)

0241 Scenarios as a tool for decision making in case of the 70-gene signature for breast cancer patients

Breast (Edinburgh), 2009, Vol.18, p.S78-S78

2009

Volltextzugriff (PDF)

Evaluating quality of patient care communication in integrated care settings: a mixed method approach

International journal for quality in health care, 2007-10, Vol.19 (5), p.281-288

2007

Volltextzugriff (PDF)

PCN45 Systems Models to Identify Implementation Requirements for Disruptive and Complex Health Technologies: A Conceptual Model Reflecting the Organization of Whole-Genome Sequencing in Lung Cancer

Value in health, 2020-12, Vol.23, p.S429-S429

2020

Volltextzugriff (PDF)

Variation in the time to treatment for stage III and IV non-small cell lung cancer patients for hospitals in the Netherlands

Lung cancer (Amsterdam, Netherlands), 2019-08, Vol.134, p.34-41

2019

Volltextzugriff (PDF)

Personalised reimbursement: a risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients

Annals of oncology, 2019-05, Vol.30 (5), p.663-665

2019

Volltextzugriff (PDF)

PPM6 USING SCENARIO DRAFTING TO EVALUATE AND FACILITATE FUTURE ADOPTION OF TUMOR-INFILTRATING LYMPHOCYTES (TIL) THERAPY IN ADVANCED MELANOMA

Value in health, 2019-05, Vol.22, p.S334-S334

2019

Volltextzugriff (PDF)

1652P - Achieving best possible cancer treatment outcomes in care pathways through benchmarking; ABC-Benchmarking

Annals of oncology, 2019-10, Vol.30, p.v678-v678

2019

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(45)
Tagungsberichte
(1)

Sprache

Englisch
(46)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(19)
Science & Technology
(19)
Humans
(16)
Oncology
(14)
Netherlands
(7)
Hematology, Oncology And Palliative Medicine
(6)
Internal Medicine
(6)
Surveys And Questionnaires
(6)
Adult
(5)
Female
(5)
Middle Aged
(5)
Biological And Medical Sciences
(4)
Cancer
(4)
Medical Sciences
(4)
Physicians
(4)
Adjuvant Systemic Treatment
(3)
Breast Cancer
(3)
Europe
(3)
Gene Expression Profiling
(3)
Male
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study

Patient access to voice prostheses and heat and moisture exchangers: Factors influencing physician’s prescription and reimbursement in eight European countries

Scenario drafting for early technology assessment of next generation sequencing in clinical oncology

Prospective cost-effectiveness analysis of genomic profiling in breast cancer

Improving the efficiency of a chemotherapy day unit: Applying a business approach to oncology

Expert Elicitation Used for Early Technology Assessment to Inform on Cost-Effectiveness of Next Generation Sequencing

Evaluating the cost-effectiveness of multicomponent rehabilitation guidelines

SP-0544: Intensive physical training during adjuvant treatment

Early Cost-Effectiveness Modeling for Tumor Infiltrating Lymphocytes (TIL) -Treatment Versus Ipilimumab in Metastatic Melanoma Patients

Estimating the Voi of Pivotal Studies Towards Predictive Biomarkers of High Dose Alkylating Chemotherapy in Triple Negative Breast Cancer

Early Stage Cost-Effectiveness Analysis of a Brca1-Like Test to Detect Triple Negative Breast Cancers Responsive to High Dose Alkylating Chemotherapy

PMD25 FACTORS INFLUENCING PHYSICIAN'S PRESCRIPTION AND REIMBURSEMENT OF MEDICAL DEVICES USED IN LARYNGECTOMY REHABILITATION IN EUROPE

PNS57 BUDGET IMPACT ANALYSIS OF A WEARABLE REMOTE CONTINUOUS MONITORING DEVICE TO FACILITATE EARLY DISCHARGE OF BARIATRIC SURGERY PATIENTS IMMEDIATELY AFTER POSTOPERATIVE OBSERVATION IN THE RECOVERY WARD

Excellent translational research in oncology: A journey towards novel and more effective anti-cancer therapies

207 70-Gene Signature Prospectively Predicts Prognosis of Patients with Node-negative Breast Cancer: 5 Year Follow-up of the RASTER Study

Cost-Effectiveness Of Cognitive-Behavioral Therapy And Physical Exercise For Alleviating Treatment-Induced Menopausal Symptoms In Breast Cancer Patients

Factors for a broad technology assessment of comprehensive genomic profiling in advanced cancer, a systematic review

A revolving research fund to study efficient use of expensive drugs: big wheels keep on turning

0241 Scenarios as a tool for decision making in case of the 70-gene signature for breast cancer patients

Evaluating quality of patient care communication in integrated care settings: a mixed method approach

PCN45 Systems Models to Identify Implementation Requirements for Disruptive and Complex Health Technologies: A Conceptual Model Reflecting the Organization of Whole-Genome Sequencing in Lung Cancer

Variation in the time to treatment for stage III and IV non-small cell lung cancer patients for hospitals in the Netherlands

Personalised reimbursement: a risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients

PPM6 USING SCENARIO DRAFTING TO EVALUATE AND FACILITATE FUTURE ADOPTION OF TUMOR-INFILTRATING LYMPHOCYTES (TIL) THERAPY IN ADVANCED MELANOMA

1652P - Achieving best possible cancer treatment outcomes in care pathways through benchmarking; ABC-Benchmarking

Suchergebnisse filtern